BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tanwar S, Khan SA, Grover VPB, Gwilt C, Smith B, Brown A. Liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2009; 15(44): 5511-5516 [PMID: 19938188 DOI: 10.3748/wjg.15.5511]
URL: https://www.wjgnet.com/1007-9327/full/v15/i44/5511.htm
Number Citing Articles
1
Eleazar Chaib, Maria Cristina França de Oliveira, Flavio Henrique Ferreira Galvão, Felipe Duarte Silva, Luiz Augusto Carneiro D’Albuquerque, Eduardo Massad. Theoretical impact of an anti-HCV vaccine on the annual number of liver transplantationMedical Hypotheses 2010; 75(3): 324 doi: 10.1016/j.mehy.2010.03.013
2
Gyula Végső, Dénes Görög, Imre Fehérvári, Balázs Nemes, Attila Doros, Róbert Miklós Langer, László Kóbori. Role of Organ Transplantation in the Treatment of Malignancies – Hepatocellular Carcinoma as the Most Common Tumour Treated with TransplantationPathology & Oncology Research 2012; 18(1): 1 doi: 10.1007/s12253-011-9441-4
3
Alton B. Farris, Nevra Dursun, Renumathy Dhanasekaran, Ipek Coban, Emily B. McIntosh, N. Volkan Adsay, Hyun S. Kim. Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapyPathology - Research and Practice 2012; 208(1): 15 doi: 10.1016/j.prp.2011.10.005
4
Achim Weber. Medical Care of the Liver Transplant Patient2012; : 332 doi: 10.1002/9781444398441.ch30
5
Andrea Mancuso. Hepatocellular carcinoma in thalassemia: A critical reviewWorld Journal of Hepatology 2010; 2(5): 171-174 doi: 10.4254/wjh.v2.i5.171
6
Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinomaClinical and Molecular Hepatology 2016; 22(4): 450 doi: 10.3350/cmh.2016.0036
7
Janio Szklaruk, Eddie K. Abdalla, Ahmed O. Kaseb, Sunil Krishnan. Oncologic Imaging: A Multidisciplinary Approach2012; : 95 doi: 10.1016/B978-1-4377-2232-1.00009-7
8
Ayman Zaki Azzam. Liver transplantation as a management of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(10): 1347-1354 doi: 10.4254/wjh.v7.i10.1347
9
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinomaPeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
10
Piero Boraschi, Maria Clotilde Della Pina, Francescamaria Donati. Graft complications following orthotopic liver transplantation: Role of non-invasive cross-sectional imaging techniquesEuropean Journal of Radiology 2016; 85(7): 1271 doi: 10.1016/j.ejrad.2016.04.008
11
T. Livraghi, H. Mäkisalo, P.-D. Line. Treatment Options in Hepatocellular Carcinoma TodayScandinavian Journal of Surgery 2011; 100(1): 22 doi: 10.1177/145749691110000105
12
R. Anghel. Hepatocellular carcinoma – a challenge for oncologistsmemo - Magazine of European Medical Oncology 2010; 3(3): 97 doi: 10.1007/s12254-010-0209-4
13
Sene Waly Raphael, Zhang Yangde, Chen YuXiang. Hepatocellular Carcinoma: Focus on Different Aspects of ManagementISRN Oncology 2012; 2012: 1 doi: 10.5402/2012/421673
14
Martina Brandlhuber, Marco Armbruster, Blaž Zupanc, Paola Coan, Emmanuel Brun, Wieland Sommer, Markus Rentsch. A Novel and Sensitive Approach for the Evaluation of Liver Ischemia-Reperfusion Injury After Liver TransplantationInvestigative Radiology 2016; 51(3): 170 doi: 10.1097/RLI.0000000000000220
15
D. Xia, H.-Q. Zuo, Y. Quan, H.-L. Dong, L. Xu. Ethical Selection on Liver Transplantation and Abandoning Treatment for Hepatocellular Carcinoma in ChinaTransplantation Proceedings 2011; 43(7): 2656 doi: 10.1016/j.transproceed.2011.06.062
16
Mathematical Approaches to Liver Transplantation2020; : 153 doi: 10.1016/B978-0-12-817436-4.16001-1
17
Ruey-Shyang Soong, Ming-Chin Yu, Kun-Ming Chan, Hong-Shiue Chou, Ting-Jung Wu, Chen-Fang Lee, Tsung-Han Wu, Wei-Chen Lee. Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomyWorld Journal of Surgical Oncology 2011; 9(1) doi: 10.1186/1477-7819-9-9